AMP Capital Investors Ltd Buys 10,405 Shares of Xylem Inc (XYL)

AMP Capital Investors Ltd raised its stake in shares of Xylem Inc (NYSE:XYL) by 14.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 84,894 shares of the industrial products company’s stock after purchasing an additional 10,405 shares during the period. AMP Capital Investors Ltd’s holdings in Xylem were worth $5,720,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. BlackRock Inc. grew its holdings in Xylem by 0.6% during the first quarter. BlackRock Inc. now owns 14,219,306 shares of the industrial products company’s stock valued at $1,093,749,000 after purchasing an additional 89,246 shares during the period. Parnassus Investments CA grew its holdings in Xylem by 1.2% during the second quarter. Parnassus Investments CA now owns 6,171,524 shares of the industrial products company’s stock valued at $415,837,000 after purchasing an additional 74,982 shares during the period. Janus Henderson Group PLC grew its holdings in Xylem by 38.1% during the second quarter. Janus Henderson Group PLC now owns 3,189,273 shares of the industrial products company’s stock valued at $214,898,000 after purchasing an additional 880,125 shares during the period. USS Investment Management Ltd grew its holdings in Xylem by 43.7% during the second quarter. USS Investment Management Ltd now owns 2,615,320 shares of the industrial products company’s stock valued at $176,220,000 after purchasing an additional 795,628 shares during the period. Finally, Bank of New York Mellon Corp grew its holdings in Xylem by 5.8% during the second quarter. Bank of New York Mellon Corp now owns 2,006,332 shares of the industrial products company’s stock valued at $135,187,000 after purchasing an additional 109,516 shares during the period. 85.83% of the stock is owned by institutional investors and hedge funds.

NYSE XYL opened at $80.93 on Friday. The stock has a market capitalization of $14.37 billion, a PE ratio of 33.72, a price-to-earnings-growth ratio of 1.53 and a beta of 1.26. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.43 and a quick ratio of 1.02. Xylem Inc has a twelve month low of $62.19 and a twelve month high of $81.32.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.02. The firm had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.28 billion. Xylem had a return on equity of 19.04% and a net margin of 7.39%. The business’s quarterly revenue was up 13.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.59 earnings per share. equities research analysts predict that Xylem Inc will post 2.91 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 20th. Stockholders of record on Thursday, August 30th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date is Wednesday, August 29th. Xylem’s dividend payout ratio (DPR) is 35.00%.

Several research firms have issued reports on XYL. Raymond James began coverage on Xylem in a report on Wednesday, September 5th. They set an “outperform” rating and a $90.00 price target for the company. Zacks Investment Research raised Xylem from a “sell” rating to a “hold” rating and set a $84.00 price objective for the company in a research note on Thursday, August 2nd. Robert W. Baird reaffirmed a “hold” rating and issued a $80.00 price objective on shares of Xylem in a research note on Wednesday, August 1st. Canaccord Genuity reaffirmed a “hold” rating and issued a $78.00 price objective on shares of Xylem in a research note on Wednesday, August 1st. Finally, BMO Capital Markets upped their price objective on Xylem from $83.00 to $84.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 1st. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $82.82.

In related news, insider Paul A. Stellato sold 3,000 shares of the business’s stock in a transaction dated Monday, September 10th. The stock was sold at an average price of $78.63, for a total value of $235,890.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Curtis J. Crawford sold 1,323 shares of the business’s stock in a transaction dated Friday, August 3rd. The stock was sold at an average price of $75.25, for a total value of $99,555.75. Following the completion of the sale, the director now owns 40,421 shares in the company, valued at $3,041,680.25. The disclosure for this sale can be found here. Insiders sold 30,623 shares of company stock worth $2,320,592 over the last quarter. 0.81% of the stock is owned by company insiders.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Featured Article: Index Funds

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply